Related Experiment Video
Updated: May 17, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage
1London School of Economics and Political Science, LSE Health, Houghton Street, London WC2A 2AE, United Kingdom. e.m.nicod@lse.ac.uk
Health Technology Assessment (HTA) recommendations vary significantly across countries, with 46% of drug-indication pairs showing differing decisions. Tailoring HTA to specific conditions can improve methods and transparency.
Area of Science:
- Health economics
- Health policy
- Comparative effectiveness research
Background:
- Health Technology Assessment (HTA) plays a crucial role in healthcare decision-making.
- International variations in HTA recommendations can lead to inequities in access to new medicines.
Purpose of the Study:
- To identify divergences in HTA recommendations across five countries.
- To understand the underlying rationale for HTA decision-making in specific therapeutic areas.
- To propose strategies for harmonizing HTA recommendations internationally.
Main Methods:
- Comparative analysis of 287 drug-indication pairs appraised by HTA bodies in England, Scotland, Sweden, Canada, and Australia (2007-2009).
- In-depth case study analysis of two selected therapeutic categories.
- Quantitative assessment of agreement using kappa scores and exploration of associations via correspondence analysis.
Main Results:
- A substantial 46% of drug-indication pairs received divergent HTA recommendations across the studied countries.
- The agreement level between HTA agencies was found to be poor to moderate.
- Therapy-specific patterns emerged, with differing expectations for relative effectiveness based on drug and disease characteristics, despite homogeneous agency guidelines.
Conclusions:
- Acknowledging and incorporating the unique characteristics of individual conditions into HTA processes is essential for methodological improvement.
- Increasing transparency regarding HTA bodies' expectations for relative effectiveness, tailored to specific disease contexts, is recommended.
- This approach can help minimize inter-country differences in HTA recommendations and promote more equitable access to innovative therapies.
Related Concept Videos
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
Bioequivalence of Drugs: Drugs with Multiple Indications
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
